Revance Therapeutics Inc (NASDAQ:RVNC)
| 13.02 Delayed Data As of Sep 22 |  +0.55 / +4.41%Today’s Change | 11.10 Today|||52-Week Range 37.98 | -29.47% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Foley Mark J Chief Executive Officer |  Sale | 5/15/2023 | 70,447 | $34.55 | $2.4M | -61.58% |
Foley Mark J Chief Executive Officer | Sale | 3/09/2023 | 70,390 | $31.59 | $2.2M | -57.99% |
Foley Mark J Chief Executive Officer | Sale | 10/13/2022 | 49,274 | $26.97 | $1.3M | -51.76% |
Foley Mark J Chief Executive Officer | Sale | 6/09/2023 | 31,279 | $30.72 | $960.9K | -56.44% |
Foley Mark J Chief Executive Officer | Sale | 8/11/2023 | 48,064 | $18.91 | $908.9K | -31.20% |
Schilke Tobin C Chief Financial Officer | Sale | 5/15/2023 | 21,401 | $34.55 | $739.4K | -61.58% |
Moxie Dwight Secretary, Senior Vice President & General Counsel | Sale | 5/15/2023 | 21,401 | $34.55 | $739.4K | -61.58% |
Sjuts Dustin S President | Sale | 5/15/2023 | 21,015 | $34.55 | $726.1K | -61.58% |
Sjuts Dustin S President | Sale | 3/09/2023 | 21,508 | $31.59 | $679.4K | -57.99% |
Foley Mark J Chief Executive Officer | Sale | 7/03/2023 | 26,279 | $24.94 | $655.4K | -48.11% |
Page of 6